The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Targeting the NLRP3 Inflammasome in Severe COVID-19
Open accessAbstract
. It is an enveloped single-stranded positive-sense RNA virus. Since December of 2019, a global expansion of the infection has occurred with widespread dissemination of coronavirus disease 2019 (COVID-19). COVID-19 often manifests as only mild cold-like symptomatology, but severe disease with complications occurs in 15% of cases. Respiratory failure occurs in severe disease that can be accompanied by a systemic inflammatory reaction characterized by inflammatory cytokine release. In severe cases, fatality is caused by the rapid development of severe lung injury characteristic of acute respiratory distress syndrome (ARDS). Although ARDS is a complication of SARS-CoV-2 infection, it is not viral replication or infection that causes tissue injury; rather, it is the result of dysregulated hyperinflammation in response to viral infection. This pathology is characterized by intense, rapid stimulation of the innate immune response that triggers activation of the Nod-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome pathway and release of its products including the proinflammatory cytokines IL-6 and IL-1β. Here we review the literature that describes the pathogenesis of severe COVID-19 and NLRP3 activation and describe an important role in targeting this pathway for the treatment of severe COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedRetracted: Interleukin‐1 blockade treatment decreasing cardiovascular risk
Zheng, Z., Zeng, X., Nie, X., Cheng, Y., Liu, J., Lin, X., Yao, H., Ji, C., Chen, X., Fan, J., et al. (2019) · Clinical Cardiology · doi:10.1002/clc.23246 · Cited by 20
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Pyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,183
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.-H., Zhong, C.-Q., & Han, J. (2015) · Cell Research · doi:10.1038/cr.2015.139 · Cited by 2,517
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472
COVID-19 and its implications for thrombosis and anticoagulation
Connors, J. M., & Levy, J. H. (2020) · Blood · doi:10.1182/blood.2020006000 · Cited by 2,369
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,147
Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Zhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
Shimabukuro-Vornhagen, A., Gödel, P., Subklewe, M., Stemmler, H. J., Schlößer, H. A., Schlaak, M., Kochanek, M., Böll, B., & von Bergwelt-Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,656
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012410 · Cited by 1,625
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,419
Norelli, M., Camisa, B., Barbiera, G., Falcone, L., Purevdorj, A., Genua, M., Sanvito, F., Ponzoni, M., Doglioni, C., Cristofori, P., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0036-4 · Cited by 1,406 · cited 9×
“Similarly, the IL-1 receptor antagonist anakinra improves CAR-T cell therapy CRS outcomes and also significantly increases survival of SARS-CoV-infected mice with hyperactive NLRP3 inflammasomes (186, 189, 190).”
BackgroundMethodInfluentialUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
Characterization of the reconstructed 1918 Spanish influenza pandemic virus
Tumpey, T. M., Basler, C. F., Aguilar, P. V., Zeng, H., Solórzano, A., Swayne, D. E., Cox, N. J., Katz, J. M., Taubenberger, J. K., Palese, P., et al. (2005) · Science · doi:10.1126/science.1119392 · Cited by 1,327
Avian Influenza A (H5N1) Infection in Humans
(2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,285
CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Giavridis, T., van der Stegen, S. J. C., Eyquem, J., Hamieh, M., Piersigilli, A., & Sadelain, M. (2018) · Nature Medicine · doi:10.1038/s41591-018-0041-7 · Cited by 1,272 · cited 1×
“Similarly, the IL-1 receptor antagonist anakinra improves CAR-T cell therapy CRS outcomes and also significantly increases survival of SARS-CoV-infected mice with hyperactive NLRP3 inflammasomes (186, 189, 190).”
BackgroundRecent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang, Y., Wang, H., Kouadir, M., Song, H., & Shi, F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1413-8 · Cited by 1,269
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237 · cited 1×
“Downregulation of ACE2 is associated with both SARS-CoV and SARS-CoV-2 disease severity (21, 120, 121); this contrasts with a minimally symptomatic coronavirus strain, HCoV-NL63, that utilizes but does not cleave or downmodulate the ACE2 receptor (122).”
Conti, P. (2020) · Journal of Biological Regulators and Homeostatic Agents · doi:10.23812/conti-e · Cited by 1,227
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2014) · Nature · doi:10.1038/nature12940 · Cited by 1,179
The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages
Evavold, C. L., Ruan, J., Tan, Y., Xia, S., Wu, H., & Kagan, J. C. (2018) · Immunity · doi:10.1016/j.immuni.2017.11.013 · Cited by 1,115 · cited 1×
“Additionally, GSDMD can mediate IL-1β and IL-18 secretion (76, 77) and this occurs both through pathways dependent and independent of NLRP3 signaling.”
BackgroundThe calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP
Lee, G.-S., Subramanian, N., Kim, A. I., Aksentijevich, I., Goldbach-Mansky, R., Sacks, D. B., Germain, R. N., Kastner, D. L., & Chae, J. J. (2012) · Nature · doi:10.1038/nature11588 · Cited by 1,076
Astuti, I., & Ysrafil (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.020 · Cited by 1,070
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Mantovani, A., Dinarello, C. A., Molgora, M., & Garlanda, C. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.012 · Cited by 1,046
Thevarajan, I., Nguyen, T. H. O., Koutsakos, M., Druce, J., Caly, L., van de Sandt, C. E., Jia, X., Nicholson, S., Catton, M., Cowie, B., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0819-2 · Cited by 1,013
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
Pachetti, M., Marini, B., Benedetti, F., Giudici, F., Mauro, E., Storici, P., Masciovecchio, C., Angeletti, S., Ciccozzi, M., Gallo, R. C., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02344-6 · Cited by 996
Cavalli, G., De Luca, G., Campochiaro, C., Della-Torre, E., Ripa, M., Canetti, D., Oltolini, C., Castiglioni, B., Tassan Din, C., Boffini, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30127-2 · Cited by 970
Zheng, H.-Y., Zhang, M., Yang, C.-X., Zhang, N., Wang, X.-C., Yang, X.-P., Dong, X.-Q., & Zheng, Y.-T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0401-3 · Cited by 940
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934
Critical role for calcium mobilization in activation of the NLRP3 inflammasome
Murakami, T., Ockinger, J., Yu, J., Byles, V., McColl, A., Hofer, A. M., & Horng, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117765109 · Cited by 923
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Millet, J. K., & Whittaker, G. R. (2015) · Virus Research · doi:10.1016/j.virusres.2014.11.021 · Cited by 902
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Gordon, R., Albornoz, E. A., Christie, D. C., Langley, M. R., Kumar, V., Mantovani, S., Robertson, A. A. B., Butler, M. S., Rowe, D. B., O’Neill, L. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4066 · Cited by 897
Le, R. Q., Li, L., Yuan, W., Shord, S. S., Nie, L., Habtemariam, B. A., Przepiorka, D., Farrell, A. T., & Pazdur, R. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0028 · Cited by 873
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Characteristics of Health Care Personnel with COVID-19 — United States, February 12–April 9, 2020
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Burrer, S. L., de Perio, M. A., Hughes, M. M., Kuhar, D. T., Luckhaupt, S. E., McDaniel, C. J., Porter, R. M., Silk, B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e6 · Cited by 801
Persistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS
Meduri, G. U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R., & Leeper, K. (1995) · Chest · doi:10.1378/chest.107.4.1062 · Cited by 789
Fu, Y., Cheng, Y., & Wu, Y. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00207-4 · Cited by 788
Perregaux, D., & Gabel, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36591-2 · Cited by 758
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
Wen, W., Su, W., Tang, H., Le, W., Zhang, X., Zheng, Y., Liu, X., Xie, L., Li, J., Ye, J., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0168-9 · Cited by 730 · cited 1×
“blood in COVID-19 patients show increased subsets of CD14 IL-1β-producing monocytes (7).”
BackgroundInflammatory Cytokines in the BAL of Patients With ARDS
Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., & Postlethwaite, A. (1995) · Chest · doi:10.1378/chest.108.5.1303 · Cited by 695
Winkler, U., Jensen, M., Manzke, O., Schulz, H., Diehl, V., & Engert, A. (1999) · Blood · doi:10.1182/blood.v94.7.2217.419k02_2217_2224 · Cited by 657
Perrone, L. A., Plowden, J. K., García-Sastre, A., Katz, J. M., & Tumpey, T. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000115 · Cited by 623
Franchi, L., Eigenbrod, T., & Núñez, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900173 · Cited by 576
Marchetti, C., Swartzwelter, B., Gamboni, F., Neff, C. P., Richter, K., Azam, T., Carta, S., Tengesdal, I., Nemkov, T., D’Alessandro, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716095115 · Cited by 574
Nieto-Torres, J. L., DeDiego, M. L., Verdiá-Báguena, C., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Fernandez-Delgado, R., Castaño-Rodriguez, C., Alcaraz, A., Torres, J., Aguilella, V. M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004077 · Cited by 559
Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome
PARK, W. Y., GOODMAN, R. B., STEINBERG, K. P., RUZINSKI, J. T., RADELLA, F., PARK, D. R., PUGIN, J., SKERRETT, S. J., HUDSON, L. D., & MARTIN, T. R. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104013 · Cited by 547
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
Chen, I.-Y., Moriyama, M., Chang, M.-F., & Ichinohe, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00050 · Cited by 547
Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306446101 · Cited by 543
IFI16 DNA Sensor Is Required for Death of Lymphoid CD4 T Cells Abortively Infected with HIV
Monroe, K. M., Yang, Z., Johnson, J. R., Geng, X., Doitsh, G., Krogan, N. J., & Greene, W. C. (2014) · Science · doi:10.1126/science.1243640 · Cited by 511
Nieto-Torres, J. L., Verdiá-Báguena, C., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Torres, J., Aguilella, V. M., & Enjuanes, L. (2015) · Virology · doi:10.1016/j.virol.2015.08.010 · Cited by 511
Siu, K., Yuen, K., Castano‐Rodriguez, C., Ye, Z., Yeung, M., Fung, S., Yuan, S., Chan, C., Yuen, K., Enjuanes, L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802418r · Cited by 502
Duncan, J. A., Bergstralh, D. T., Wang, Y., Willingham, S. B., Ye, Z., Zimmermann, A. G., & Ting, J. P.-Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611496104 · Cited by 498
Glowacka, I., Bertram, S., Herzog, P., Pfefferle, S., Steffen, I., Muench, M. O., Simmons, G., Hofmann, H., Kuri, T., Weber, F., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01248-09 · Cited by 495
Zhao, D., Yao, F., Wang, L., Zheng, L., Gao, Y., Ye, J., Guo, F., Zhao, H., & Gao, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa247 · Cited by 488
Gasse, P., Mary, C., Guenon, I., Noulin, N., Charron, S., Schnyder-Candrian, S., Schnyder, B., Akira, S., Quesniaux, V. F. J., Lagente, V., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32285 · Cited by 481
Erratum: Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.149 · Cited by 465
Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue
Doitsh, G., Cavrois, M., Lassen, K. G., Zepeda, O., Yang, Z., Santiago, M. L., Hebbeler, A. M., & Greene, W. C. (2010) · Cell · doi:10.1016/j.cell.2010.11.001 · Cited by 452
Why tocilizumab could be an effective treatment for severe COVID-19?
Fu, B., Xu, X., & Wei, H. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02339-3 · Cited by 445
Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
Zhu, Z., Cai, T., Fan, L., Lou, K., Hua, X., Huang, Z., & Gao, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.041 · Cited by 435
Li, J.-Y., You, Z., Wang, Q., Zhou, Z.-J., Qiu, Y., Luo, R., & Ge, X.-Y. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.002 · Cited by 433
NLRP3 Inflammasome—A Key Player in Antiviral Responses
Zhao, C., & Zhao, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00211 · Cited by 432
Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis
Wu, C., Lu, W., Zhang, Y., Zhang, G., Shi, X., Hisada, Y., Grover, S. P., Zhang, X., Li, L., Xiang, B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.003 · Cited by 417
Shi, C.-S., Nabar, N. R., Huang, N.-N., & Kehrl, J. H. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0181-7 · Cited by 404
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Porter, D., Frey, N., Wood, P. A., Weng, Y., & Grupp, S. A. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0571-y · Cited by 401
The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation
Di, A., Xiong, S., Ye, Z., Malireddi, R. K. S., Kometani, S., Zhong, M., Mittal, M., Hong, Z., Kanneganti, T.-D., Rehman, J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.032 · Cited by 398
DeDiego, M. L., Nieto-Torres, J. L., Regla-Nava, J. A., Jimenez-Guardeño, J. M., Fernandez-Delgado, R., Fett, C., Castaño-Rodriguez, C., Perlman, S., & Enjuanes, L. (2014) · Journal of Virology · doi:10.1128/jvi.02576-13 · Cited by 394
Abbate, A., Van Tassell, B. W., Biondi-Zoccai, G., Kontos, M. C., Grizzard, J. D., Spillman, D. W., Oddi, C., Roberts, C. S., Melchior, R. D., Mueller, G. H., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.287 · Cited by 393
Lau, S. K. P., Lau, C. C. Y., Chan, K.-H., Li, C. P. Y., Chen, H., Jin, D.-Y., Chan, J. F. W., Woo, P. C. Y., & Yuen, K.-Y. (2013) · Journal of General Virology · doi:10.1099/vir.0.055533-0 · Cited by 392
Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory Syndrome: A Preliminary Study
Loutfy, M. R., Blatt, L. M., Siminovitch, K. A., Ward, S., Wolff, B., Lho, H., Pham, D. H., Deif, H., LaMere, E. A., Chang, M., et al. (2003) · JAMA · doi:10.1001/jama.290.24.3222 · Cited by 381
Fung, S.-Y., Yuen, K.-S., Ye, Z.-W., Chan, C.-P., & Jin, D.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1736644 · Cited by 381
Patel, A. B., & Verma, A. (2020) · JAMA · doi:10.1001/jama.2020.4812 · Cited by 378
He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 366
Min, C.-K., Cheon, S., Ha, N.-Y., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J.-Y., Inn, K.-S., Kim, J.-H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 364
Schmitz, N., Kurrer, M., Bachmann, M. F., & Kopf, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6441-6448.2005 · Cited by 363
Tang, T., Lang, X., Xu, C., Wang, X., Gong, T., Yang, Y., Cui, J., Bai, L., Wang, J., Jiang, W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00227-x · Cited by 361
Triantafilou, K., Hughes, T. R., Triantafilou, M., & Morgan, B. P. (2013) · Journal of Cell Science · doi:10.1242/jcs.124388 · Cited by 360
Inflammasomes: current understanding and open questions
Bauernfeind, F., Ablasser, A., Bartok, E., Kim, S., Schmid-Burgk, J., Cavlar, T., & Hornung, V. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0567-4 · Cited by 359
van der Heijden, T., Kritikou, E., Venema, W., van Duijn, J., van Santbrink, P. J., Slütter, B., Foks, A. C., Bot, I., & Kuiper, J. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309575 · Cited by 348 · cited 1×
“The NLRP3 inhibitors arglabin and MCC950 reduced IL-1β plasma levels and decreased atherosclerotic lesion size (48, 192).”
BackgroundSendler, M., van den Brandt, C., Glaubitz, J., Wilden, A., Golchert, J., Weiss, F. U., Homuth, G., De Freitas Chama, L. L., Mishra, N., Mahajan, U. M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.040 · Cited by 346
Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates
Smits, S. L., de Lang, A., van den Brand, J. M. A., Leijten, L. M., van IJcken, W. F., Eijkemans, M. J. C., van Amerongen, G., Kuiken, T., Andeweg, A. C., Osterhaus, A. D. M. E., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000756 · Cited by 335
Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host
Ahn, M., Anderson, D. E., Zhang, Q., Tan, C. W., Lim, B. L., Luko, K., Wen, M., Chia, W. N., Mani, S., Wang, L. C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0371-3 · Cited by 334
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
Kotch, C., Barrett, D., & Teachey, D. T. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1629904 · Cited by 324
Lu, W., Zheng, B.-J., Xu, K., Schwarz, W., Du, L., Wong, C. K. L., Chen, J., Duan, S., Deubel, V., & Sun, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605402103 · Cited by 321
CHATENOUD, L., FERRAN, C., LEGENDRE, C., THOUARD, I., MERITE, S., REUTER, A., GEVAERT, Y., KREIS, H., FRANCHIMONT, P., & BACH, J.-F. (1990) · Transplantation · doi:10.1097/00007890-199004000-00009 · Cited by 320
Castaño-Rodriguez, C., Honrubia, J. M., Gutiérrez-Álvarez, J., DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Fernandez-Delgado, R., Verdia-Báguena, C., Queralt-Martín, M., et al. (2018) · mBio · doi:10.1128/mbio.02325-17 · Cited by 313
Monteleone, M., Stanley, A. C., Chen, K. W., Brown, D. L., Bezbradica, J. S., von Pein, J. B., Holley, C. L., Boucher, D., Shakespear, M. R., Kapetanovic, R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.027 · Cited by 306
Zhao, M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105982 · Cited by 274
Dissecting How CD4 T Cells Are Lost During HIV Infection
Doitsh, G., & Greene, W. C. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.012 · Cited by 273
(1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202117 · Cited by 269
Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia
Gupta, N., Sahu, A., Prabhakar, A., Chatterjee, T., Tyagi, T., Kumari, B., Khan, N., Nair, V., Bajaj, N., Sharma, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620458114 · Cited by 263
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
Liu, D., Zeng, X., Li, X., Mehta, J. L., & Wang, X. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-017-0663-9 · Cited by 258
Wing, M. G., Moreau, T., Greenwood, J., Smith, R. M., Hale, G., Isaacs, J., Waldmann, H., Lachmann, P. J., & Compston, A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119110 · Cited by 257
Inflammasomes in Tissue Damages and Immune Disorders After Trauma
Bortolotti, P., Faure, E., & Kipnis, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01900 · Cited by 257
Sun, H.-J., Ren, X.-S., Xiong, X.-Q., Chen, Y.-Z., Zhao, M.-X., Wang, J.-J., Zhou, Y.-B., Han, Y., Chen, Q., Li, Y.-H., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.470 · Cited by 243
Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS
Walsh, J. G., Reinke, S. N., Mamik, M. K., McKenzie, B. A., Maingat, F., Branton, W. G., Broadhurst, D. I., & Power, C. (2014) · Retrovirology · doi:10.1186/1742-4690-11-35 · Cited by 231
SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death
Yue, Y., Nabar, N. R., Shi, C.-S., Kamenyeva, O., Xiao, X., Hwang, I.-Y., Wang, M., & Kehrl, J. H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0917-y · Cited by 231
Interleukin-1β Causes Acute Lung Injury via αvβ5 and αvβ6 Integrin–Dependent Mechanisms
Ganter, M. T., Roux, J., Miyazawa, B., Howard, M., Frank, J. A., Su, G., Sheppard, D., Violette, S. M., Weinreb, P. H., Horan, G. S., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.161067 · Cited by 228
Perregaux, D. G., McNiff, P., Laliberte, R., Hawryluk, N., Peurano, H., Stam, E., Eggler, J., Griffiths, R., Dombroski, M. A., & Gabel, C. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29317-4 · Cited by 216
K+ regulates Ca2+ to drive inflammasome signaling: dynamic visualization of ion flux in live cells
Yaron, J. R., Gangaraju, S., Rao, M. Y., Kong, X., Zhang, L., Su, F., Tian, Y., Glenn, H. L., & Meldrum, D. R. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.277 · Cited by 212
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Zhang, S., Li, L., Shen, A., Chen, Y., & Qi, Z. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00917-3 · Cited by 212
Lau, S. K. P., Feng, Y., Chen, H., Luk, H. K. H., Yang, W.-H., Li, K. S. M., Zhang, Y.-Z., Huang, Y., Song, Z.-Z., Chow, W.-N., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01048-15 · Cited by 193
Cytokine Release Syndrome: Current Perspectives
Murthy, H., Iqbal, M., Chavez, J. C., & Kharfan-Dabaja, M. A. (2019) · ImmunoTargets and Therapy · doi:10.2147/itt.s202015 · Cited by 178
Coronavirus virulence genes with main focus on SARS-CoV envelope gene
DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Usera, F., & Enjuanes, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.024 · Cited by 177
Schmidt, F. I., Lu, A., Chen, J. W., Ruan, J., Tang, C., Wu, H., & Ploegh, H. L. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151790 · Cited by 177
Abderrazak, A., Couchie, D., Mahmood, D. F. D., Elhage, R., Vindis, C., Laffargue, M., Matéo, V., Büchele, B., Ayala, M. R., El Gaafary, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013730 · Cited by 176
Segovia, M., Russo, S., Jeldres, M., Mahmoud, Y. D., Perez, V., Vega, M. D., Charnet, P., Rousset, M., Victoria, S., Veigas, F., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.003 · Cited by 175
Domingo-Fernández, R., Coll, R. C., Kearney, J., Breit, S., & O'Neill, L. A. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797126 · Cited by 170
Abboud, R., Keller, J., Slade, M., DiPersio, J. F., Westervelt, P., Rettig, M. P., Meier, S., Fehniger, T. A., Abboud, C. N., Uy, G. L., et al. (2016) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2016.06.010 · Cited by 169
Marchetti, C., Swartzwelter, B., Koenders, M. I., Azam, T., Tengesdal, I. W., Powers, N., de Graaf, D. M., Dinarello, C. A., & Joosten, L. A. B. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1664-2 · Cited by 164
Sánchez-Fernández, A., Skouras, D. B., Dinarello, C. A., & López-Vales, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02578 · Cited by 164
Galloway, N. L. K., Doitsh, G., Monroe, K. M., Yang, Z., Muñoz-Arias, I., Levy, D. N., & Greene, W. C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.011 · Cited by 160
Severe cytokine release syndrome in a patient receiving PD‐1‐directed therapy
Rotz, S. J., Leino, D., Szabo, S., Mangino, J. L., Turpin, B. K., & Pressey, J. G. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26642 · Cited by 158
Toldo, S. A., Mauro, A. G., Cutter, Z., Tassell, B. W. V., Mezzaroma, E., Buono, M. G. D., Prestamburgo, A., Potere, N., & Abbate, A. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000658 · Cited by 158
Velázquez-Salinas, L., Zárate, S., Eberl, S., Gladue, D. P., Novella, I. S., & Borca, M. V. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.550674 · Cited by 153
Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines
Barker, B. R., Taxman, D. J., & Ting, J. P. ‐. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.005 · Cited by 141
AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality
Zhang, H., Luo, J., Alcorn, J. F., Chen, K., Fan, S., Pilewski, J. M., Liu, A., Chen, W., Kolls, J. K., & Wang, J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600714 · Cited by 134
Lin, L., Xu, L., Lv, W., Han, L., Xiang, Y., Fu, L., Jin, M., Zhou, R., Chen, H., & Zhang, A. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007795 · Cited by 134
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
Qiao, J., Wu, X., Luo, Q., Wei, G., Xu, M., Wu, Y., Liu, Y., Li, X., Zi, J., Ju, W., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.191700 · Cited by 133
Olman, M. A., White, K. E., Ware, L. B., Simmons, W. L., Benveniste, E. N., Zhu, S., Pugin, J., & Matthay, M. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2668 · Cited by 127
Principles and properties of ion flow in P2X receptors
Samways, D. S. K., Li, Z., & Egan, T. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00006 · Cited by 120
Taccone, F. S., Gorham, J., & Vincent, J. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30172-7 · Cited by 118
Alosaimi, B., Hamed, M. E., Naeem, A., Alsharef, A. A., Alqahtani, S. Y., Aldosari, K., Alamri, A. A., Al-Eisa, K., Khojah, T., Assiri, A. M., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154895 · Cited by 117
Murthy, P., Durco, F., Miller-Ocuin, J. L., Takedai, T., Shankar, S., Liang, X., Liu, X., Cui, X. D., Sachdev, U., Rath, D., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.161 · Cited by 114
Abbate, A., Tassell, B. W. V., Seropian, I. M., Toldo, S. A., Robati, R., Varma, A., Salloum, F. N., Smithson, L. A., & Dinarello, C. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq017 · Cited by 113
Schumacher, H. R., Sundy, J. S., Terkeltaub, R. A., Knapp, H. R., Mellis, S. J., Stahl, N., Yancopoulos, G. D., Soo, Y., King-Davis, S., Weinstein, S. P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33412 · Cited by 110
Ren, X., Tong, Y., Ling, L., Chen, D., Sun, H., Zhou, H., Qi, X., Chen, Q., Li, Y., Kang, Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486061 · Cited by 107
de Vos, S., Forero, A., Ansell, S. M., Kahl, B. S., Cheson, B. D., Bartlett, N. L., Furman, R. R., Winter, J. N., Kaplan, H. G., Timmerman, J. M., et al. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-44 · Cited by 105
NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis
Zhao, C., Gu, Y., Zeng, X., & Wang, J. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.09.007 · Cited by 103
Aue, G., Njuguna, N., Tian, X., Soto, S., Hughes, T. E., Vire, B., Keyvanfar, K., Gibellini, F., Valdez, J., Boss, C., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.005835 · Cited by 99
Blech, M., Peter, D., Fischer, P., Bauer, M., Hafner, M., Zeeb, M., & Nar, H. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.09.021 · Cited by 99
Kim, K. S., Jung, H., Shin, I. K., Choi, B.-R., & Kim, D. H. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24138 · Cited by 93
XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases
Owyang, A. M., Issafras, H., Corbin, J., Ahluwalia, K., Larsen, P., Pongo, E., Handa, M., Horwitz, A. H., Roell, M. K., Haak‐Frendscho, M., et al. (2011) · mAbs · doi:10.4161/mabs.3.1.13989 · Cited by 93
Pyroptosis: Caspase-11 Unlocks the Gates of Death
Gassart, A. D., & Martinon, F. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.024 · Cited by 92
Freeman, C. L., Morschhauser, F., Sehn, L. H., Dixon, M., Houghton, R., Lamy, T., Fingerle‐Rowson, G., Wassner-Fritsch, E., Gribben, J. G., Hallek, M. J., et al. (2015) · Blood · doi:10.1182/blood-2015-09-670802 · Cited by 92
Ikonomidis, I., Tzortzis, S., Lekakis, J., PARASKEVAIDIS, I. A., Andreadou, I., Nikolaou, M., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., et al. (2009) · Heart · doi:10.1136/hrt.2009.168971 · Cited by 88
Toldo, S. A., Mezzaroma, E., Bressi, E., Marchetti, C., Carbone, S., Sonnino, C., Tassell, B. W. V., & Abbate, A. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000106 · Cited by 86
Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome
Shim, D.-W., & Lee, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01054 · Cited by 84
Tan, H. Y., Yong, Y. K., Shankar, E. M., Paukovics, G., Ellegård, R., Larsson, M., Kamarulzaman, A., French, M. A., & Crowe, S. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502203 · Cited by 78
Bouros, D. E., Alexandrakis, M. G., Antoniou, K. M., Agouridakis, P., Pneumatikos, I. A., Anevlavis, S., Pataka, A., Patlakas, G., Karkavitsas, N. S., & Kyriakou, D. (2004) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-4-6 · Cited by 75
Re, L., Baeza-Noci, J., Serra, M. E. G., Mollica, P. J., Bonetti, M., & Travagli, V. (2020) · PubMed · Cited by 72
Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats
Leff, J. A., Baer, J. W., Bodman, M. E., Kirkman, J. M., Shanley, P. F., Patton, L. M., Beehler, C. J., McCord, J. M., & Repine, J. E. (1994) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1994.266.1.l2 · Cited by 68
Wen, Y., Liu, Y., Tang, T., Lv, L., Liu, H., Ma, K., & Liu, B. (2016) · Oncotarget · doi:10.18632/oncotarget.11091 · Cited by 66
Xu, L., Zhang, C., Jiang, N., He, D., Bai, Y., & Xin, Y. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27792 · Cited by 66
Virus-induced inflammasome activation is suppressed by prostaglandin D 2 /DP1 signaling
Vijay, R., Fehr, A. R., Janowski, A. M., Athmer, J., Wheeler, D. L., Grunewald, M. E., Sompallae, R. R., Kurup, S. P., Meyerholz, D. K., Sutterwala, F. S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704099114 · Cited by 65
Inflammasomes in infection and inflammation
McIntire, C. R., Yeretssian, G., & Saleh, M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0312-3 · Cited by 64
Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.
Tonini, G., Santini, D., Vincenzi, B., Borzomati, D., Dicuonzo, G., Cesa, A. L., Onori, N., & Coppola, R. (2002) · PubMed · Cited by 63
Caspases and inflammasomes in metabolic inflammation
Skeldon, A. M., Faraj, M., & Saleh, M. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.5 · Cited by 61
Sun, N.-N., Yu, C., Pan, M., Zhang, Y., Zheng, B., Yang, Q., Zheng, Z., & Meng, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-13305-3 · Cited by 61
Swine acute diarrhea syndrome coronavirus-induced apoptosis is caspase- and cyclophilin D- dependent
Zhang, J., Han, Y., Shi, H., Chen, J., Zhang, X., Wang, X., Zhou, L., Liu, J., Zhang, J., Ji, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1722758 · Cited by 56
Advancing scientific knowledge in times of pandemics
The Sinai Immunology Review Project, Vabret, N., Trainees, Faculty, Samstein, R., Fernandez, N., & Merad, M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0319-0 · Cited by 53
Yang, C.-A., Huang, S.-T., & Chiang, B. (2013) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2013.834962 · Cited by 42
Tan, Y., Lim, S. G., & Hong, W. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01034.x · Cited by 42
Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications
An, P., Zhu, Y. Z., & Yang, L.-P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104946 · Cited by 42
Lundemose, J. B., Smith, H. C., & Sweet, C. R. (1993) · PubMed · Cited by 41
Knickelbein, J. E., Tucker, W. R., Bhatt, N. P., Armbrust, K. R., Valent, D. J., Obiyor, D., Nussenblatt, R. B., & Sen, H. N. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.09.017 · Cited by 34
Inflammasome: Putting the Pieces Together
Ruland, J. (2014) · Cell · doi:10.1016/j.cell.2014.02.038 · Cited by 32
Alig, S., Dreyling, M. H., Seppi, B., Aulinger, B. A., Witkowski, L., & Rieger, C. T. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12396 · Cited by 30
Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
Gómez-García, F. J., Sanz-Cabanillas, J. L., Viguera-Guerra, I., Isla-Tejera, B., Nieto, A. V.-G., & Ruano, J. (2018) · Dermatology and Therapy · doi:10.1007/s13555-018-0269-7 · Cited by 29
Interleukin-1?-induced neutrophil recruitment and acute lung injury in hamsters
Patton, L. M., Saggart, B. S., Ahmed, N. K., Leff, J. A., & Repine, J. E. (1995) · Inflammation · doi:10.1007/bf01534377 · Cited by 28
Cho, C., & Perales, M. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.229 · Cited by 21
Cited by
Role of pyroptosis in inflammation and cancer
Wei, X., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., Huang, J., Wang, F., Zhou, F., & Zhang, L. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00905-x · Cited by 699
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Zimmermann, P., & Curtis, N. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-320338 · Cited by 502
Lessons from the host defences of bats, a unique viral reservoir
Irving, A. T., Ahn, M., Goh, G., Anderson, D. E., & Wang, L.-F. (2021) · Nature · doi:10.1038/s41586-020-03128-0 · Cited by 413
Pyroptosis-Induced Inflammation and Tissue Damage
Vasudevan, S. O., Behl, B., & Rathinam, V. A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101781 · Cited by 412
Metadata
- Authors
- Freeman, T. L., & Swartz, T. H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-23
- Volume
- 11
- Pages
- 1518-1518
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3037490455
- Cited by
- 405
- References
- 201
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.